ArticleJournal of global health2025

Cost-effectiveness of introducing a maternal vaccine or long-acting monoclonal antibody to prevent infant respiratory syncytial virus disease in Nepal.

Neele Rave et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.